Can a new infusion drug boost stroke recovery?

This phase II trial is testing whether an experimental drug called LT3001 can help people who have had an acute ischemic stroke, which happens when a blood clot blocks blood flow to the brain. The study will include about 300 participants who receive either a high or low dose of LT3001 or a placebo, given by intravenous infusion within 24 hours of stroke onset. The main goal is to see if the drug improves functional recovery, measured by the modified Rankin Scale, compared to placebo.